This joint workshop by VCCC Alliance and Human Genetics Society of Australasia (HGSA) examines the technical, regulatory, ethical and treatment considerations that inform management of potential germline variants detected by tumour-only testing, with particular attention to how uncertainty about variant origin shapes therapeutic recommendations and patient care pathways.
Through case studies and panel discussion, we will explore the diverse approaches employed across Australasia. The national cancer genomics community is invited to come together and address this urgent clinical need, charting a pathway towards implementing best practice across the region.
Watch on demand
Workshop recording
Recording guide Explore the sessions 14 chapters
Chapter markers are built into the player. Select a session to open that point of the recording on YouTube in a new tab.
01 Welcome and introduction (opens in a new tab) 0:00 →
02 Opening audience polls (opens in a new tab) 4:15 →
03 Background: tumour and germline testing (opens in a new tab) 6:55 →
04 Case 1: TP53 in early-onset breast cancer (opens in a new tab) 31:20 →
05 Case 2: EGFR in non-small cell lung cancer (opens in a new tab) 54:34 →
06 Case 3: DDX41 in haematology (opens in a new tab) 1:05:35 →
07 Panel: questions on the TP53 case (opens in a new tab) 1:24:58 →
08 Panel: Medicare funding for germline confirmation (opens in a new tab) 1:27:20 →
09 Panel: germline testing after a negative somatic result (opens in a new tab) 1:28:46 →
10 Panel: matched tumour–germline testing (opens in a new tab) 1:35:22 →
11 Panel: aligning practice across services (opens in a new tab) 1:41:10 →
12 Questions from the room: tumour purity (opens in a new tab) 1:45:10 →
13 Questions from the room: ctDNA, CHIP and DDX41 (opens in a new tab) 1:49:15 →
14 Closing remarks and final poll (opens in a new tab) 1:53:21 →
At a glance
The workshop in brief
Originally held
Friday 30 October 2026, 2.30pm–4.30pm AEDT
Seminar Room, Peter MacCallum Cancer Centre, and online.
Who this is for
Healthcare professionals and researchers involved in cancer genomics
Clinicians (medical specialists, nurses, allied health) and researchers involved in cancer genomics.
Objectives
— Examine the technical, regulatory, ethical and treatment considerations that inform management of potential germline variants detected by tumour-only testing
— Explore the diverse approaches in tumour-only testing employed across Australasia
Contributors
Chairs and speakers
Chair
Dr Joep Vissers
Curation Scientist Team Leader, University of Melbourne
Chair
A/Prof Laura Forrest
Senior Research Fellow and Associate Genetic Counsellor, Parkville Familial Cancer Centre
Speakers
Dr Helen Mar Fan
Clinical Geneticist, Icon Cancer Centre Wesley
Prof Paul James
Head of Adult Genetics, Department of Genomic Medicine and Director of the Parkville Familial Cancer Centre, Royal Melbourne Hospital and Peter MacCallum Cancer Centre
Dr Nicole Den Elzen
Genetic Counsellor, Peter MacCallum Cancer Centre
Rebecca Lane
Project Officer, QIMR Berghofer
Jointly organised with

Resource details
This course is brought to you by